Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
11/26/2003 | EP0673937B1 Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives |
11/26/2003 | CN1458921A Process for making N-aryl-anthranilic acid and their derivatives |
11/26/2003 | CN1128798C Pharmaceutically active tricyclic amines |
11/26/2003 | CN1128788C Benzyl(idene)-lactam derivatives, their prepn. and their use as selective(ant) agonists of 5-HT 1A and/or 5-HT 1D receptors |
11/25/2003 | US6653481 Used as calcium channel blockers |
11/25/2003 | US6653304 Antiarthritic agents; skin disorders; anticarcinogenic agents |
11/25/2003 | US6653153 Encoding metal salts are impregnated onto the support unit, with isotope distribution of the metal in the salt used as code; insoluble metal salts are formed to improve metal's retention |
11/25/2003 | US6652905 Piezoelectric element and process for production thereof |
11/25/2003 | US6652601 Agent for dyeing fibers comprising an indoline/indolium derivative |
11/25/2003 | CA2061168C The preparation and use of 3, (4)-substituted pyrrolidines as catalysts for the polyisocyanate polyaddition process |
11/20/2003 | WO2003094914A1 Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances |
11/20/2003 | WO2003013512A3 Crystalline forms of fluvastatin sodium |
11/20/2003 | US20030216583 Accelerated process for preparing O-methyl phenols, N-methyl heteroaromatic compounds, and methylated aminophenols |
11/20/2003 | US20030216572 Process to produce oxazolidinones |
11/20/2003 | US20030216569 Viricides; Aids therapy |
11/20/2003 | US20030216494 Free radical catalyst for addition polymer |
11/20/2003 | US20030216462 Anticancer agents; psoriasis |
11/20/2003 | US20030216452 Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids |
11/20/2003 | US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones |
11/20/2003 | US20030216409 Heteroaryl alkyl piperazine derivatives |
11/20/2003 | US20030216405 Hydroxycarbonyl or alkyloxycarbonyl or aminohydroxycarbonyl substituted sulfonamide compounds useful as procollagen C-protenase inhibitor |
11/20/2003 | US20030216403 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent as well as treats asthma |
11/20/2003 | US20030216381 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer |
11/20/2003 | US20030216356 Cause the selective destruction of tumour vasculature; are used to inhibit and/or reverse, and/or alleviate symptoms of angiogenesis |
11/20/2003 | US20030216260 Preparation by intramolecular cyclization |
11/20/2003 | US20030216258 Condensed heterocylic compounds and herbicides containing them as active ingredients |
11/20/2003 | US20030215667 Electroluminescent devices |
11/20/2003 | US20030215523 Medicinal compositions for concomitant use as anticancer agent |
11/20/2003 | US20030213071 Comprises mixing 5-(2,4-dimethoxyphenyl)-1,3,3-trimethyl-2-methylene-indoline and carbonyl compound (4-hydroxy-3-methoxy-benzaldehyde) for dyeing keratin fibers (wool, silk, and/or hair) |
11/20/2003 | CA2483991A1 Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances |
11/19/2003 | EP1362864A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts |
11/19/2003 | EP1362601A1 Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression |
11/19/2003 | EP1362041A1 Aryl carbamate derivatives, preparation and use thereof |
11/19/2003 | EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
11/19/2003 | EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
11/19/2003 | EP0991624B1 Phenylalkyl derivatives with thrombin-inhibiting effect |
11/19/2003 | EP0831811B1 Carbazoles for treating microbial infections |
11/19/2003 | CN1457337A Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
11/19/2003 | CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same |
11/19/2003 | CN1128138C Carbazole alkaloid derivative and its prepn and use |
11/19/2003 | CN1128137C Indole compounds and its synthetic method |
11/18/2003 | US6649772 3,6,9-Trisubstituted carbazoles for light emitting diodes |
11/18/2003 | US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
11/18/2003 | US6649641 Glucagon antagonists/inverse agonists |
11/18/2003 | US6649639 Inhibit or block the biological activity of the picornaviral 3C protease. |
11/18/2003 | US6649634 Use in treating diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemias, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals |
11/18/2003 | US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
11/13/2003 | WO2003093302A2 Process for the synthesis of peptides amides by side-chain attachement to a solid phase |
11/13/2003 | WO2003093281A1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one |
11/13/2003 | WO2003093220A1 Process for preparing highly functionalized y-butyrolactams and y-amino acids |
11/13/2003 | WO2003092679A1 Preparation of phosphatase inhibitors |
11/13/2003 | WO2003092643A1 Light-protection formulations using acrylonitrile derivatives |
11/13/2003 | WO2003092626A2 Carvedilol pharmasolve solvate |
11/13/2003 | WO2003092622A2 Carvedilol monocitrate monohydrate |
11/13/2003 | WO2003029213A9 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
11/13/2003 | WO2003024448A3 Inhibitors of histone deacetylase |
11/13/2003 | WO2003022806A3 Cbi analogues of cc-1065 and the duocarmycins |
11/13/2003 | WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases |
11/13/2003 | WO2002083622A3 Novel aminophenyl ketone derivatives |
11/13/2003 | WO2002057231A8 Benz(g) indoles and their use as spla2 inhibitors |
11/13/2003 | WO2002050030A8 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases |
11/13/2003 | WO2002050029A8 Tetracyclic derivatives as spla2 inhibitors |
11/13/2003 | WO2001040188A8 Curcumin analogues for treating cancer |
11/13/2003 | US20030212278 Using dihydropyran, triethyl orthoformate and alkyl acrylate |
11/13/2003 | US20030212140 Analgesics; central nervous system disorders |
11/13/2003 | US20030212113 Novel aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity |
11/13/2003 | US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents |
11/13/2003 | US20030212070 Dietetics; cardiovascular disorders; hypotensive agents; psychological disorders |
11/13/2003 | US20030212067 Bone disorders; rheumatic diseases; wound healing agents |
11/13/2003 | CA2484624A1 Carvedilol pharmasolve solvate |
11/13/2003 | CA2483830A1 Process for preparing highly functionalized y-butyrolactams and y-amino acids |
11/13/2003 | CA2483566A1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one |
11/13/2003 | CA2483054A1 Carvedilol monocitrate monohydrate |
11/12/2003 | EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
11/12/2003 | EP1359940A2 Combinations of statins, estrogenic agents and optionally estrogens |
11/12/2003 | EP1206444B1 Compounds that inhibit tryptase activity |
11/12/2003 | CN1455770A (2-azabicyclo [2,2,1] hept-7-yl] methanol derivatives as nicotinic acetylcholine receptor agonisis |
11/12/2003 | CN1127493C 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring |
11/12/2003 | CN1127483C Tert-butyl (3R,5R)-3, 5-dihydroxy-7-N-phthaloylimino heptanonate and its synthesis and use thereof |
11/12/2003 | CN1127482C Sulfuryl diphenyl indole compound and preparation process and use in medicine |
11/12/2003 | CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity |
11/11/2003 | US6646149 Derivitives of spermine or its N12-t-butyl carbamate |
11/11/2003 | US6646137 Non-peptide GnRH agents |
11/11/2003 | US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
11/11/2003 | US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
11/11/2003 | US6645968 Potassium channel openers |
11/11/2003 | CA2272098C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
11/06/2003 | WO2003091689A2 Bis-transition-metal-chelate-probes |
11/06/2003 | WO2003091396A2 Polypeptides and biosynthetic pathways |
11/06/2003 | WO2003091262A1 Bridged bi-aromatic ligands, complexes, catalysts and processes for polymerizing and poymers therefrom |
11/06/2003 | WO2003091215A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo’ b! thiophene-2-carboxylic acid derivatives as interieukin-4 gene expression inhibitors |
11/06/2003 | WO2003091214A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo |
11/06/2003 | WO2003091213A1 Novel amide derivatives or salts thereof |
11/06/2003 | WO2003091211A1 Novel heteroaryl compounds |
11/06/2003 | WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient |
11/06/2003 | WO2003066889A3 Assay for acytyltransferase or deacetylase activity |
11/06/2003 | WO2003057670A3 Indoles as naaladase inhibitors |
11/06/2003 | WO2003032901A3 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
11/06/2003 | WO2002094799A3 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
11/06/2003 | WO2002059117A8 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |